Features Screener Stocks Charts
Sign In Sign Up

Amrutanjan Financial Statements

NSE: AMRUTANJAN | BSE: 590006 | PHARMACEUTICALS

Showing 5 of 10 years of data. Sign up free for the full 10 years of history.

View Plans

Amrutanjan (AMRUTANJAN) reported revenue of ₹4.69B in FY2025 with net income of ₹508.35M. Total assets stood at ₹4.21B and free cash flow was ₹153.46M.

Amrutanjan Income Statement

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025
Item Chart 2021 2022 2023 2024 2025
Revenue 3.33B 4.21B 3.94B 4.38B 4.69B
Cost of Rev. -1.40B -1.80B -1.82B -2.12B -2.23B
Gross Profit 1.93B 2.41B 2.12B 2.26B 2.46B
SGA -719.15M -1.46B -1.53B -1.58B -1.70B
Op. Income 710.84M 910.61M 537.23M 621.03M 693.53M
PBT 819.05M 905.77M 536.45M 619.46M 691.34M
Net Income 611.90M 671.89M 398.35M 449.73M 508.35M
Dil. Shares 29.23M 29.24M 29.24M 29.02M 28.92M
Diluted EPS 20.93 22.98 13.63 15.56 17.58

Figures in ₹ — millions (M), billions (B), trillions (T). EPS is earnings per share.

Understanding the Income Statement

The income statement shows Amrutanjan's revenue and expenses over a period. Revenue minus costs gives gross profit; after operating expenses, interest, and taxes, the remainder is net income. Diluted EPS divides net income by all shares that could exist if options and convertibles were exercised.

Amrutanjan Balance Sheet

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025
Item Chart 2021 2022 2023 2024 2025
Curr. assets 2.24B 2.75B 2.60B 2.96B 2.91B
Non-curr. assets 501.70M 752.19M 1.03B 711.89M 1.31B
Total assets 2.74B 3.50B 3.62B 3.67B 4.21B
Curr. liabilities 521.03M 774.73M 630.12M 699.19M 845.83M
Non-curr. liab. 66.03M 72.71M 83.09M 84.64M 101.90M
Total liabilities 587.06M 847.44M 713.21M 783.82M 947.73M
Total equity 2.16B 2.65B 2.91B 2.88B 3.27B
Total liab. & eq. 2.74B 3.50B 3.62B 3.67B 4.21B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding the Balance Sheet

The balance sheet captures Amrutanjan's financial position at a point in time — what it owns (assets), what it owes (liabilities), and the residual value to shareholders (equity). Total assets always equals total liabilities plus equity.

Amrutanjan Cash Flow Statement

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025
Item Chart 2021 2022 2023 2024 2025
Net Income 819.05M 905.77M 536.45M 619.46M 691.34M
Operating CF 897.63M 521.96M 201.81M 279.09M 508.99M
Capex -19.61M -234.63M -89.27M -67.17M -355.53M
Investing CF -877.61M -362.12M -24.75M 191.66M -309.66M
Dividend Paid -46.77M -124.77M -144.09M -133.86M -132.67M
Financing CF -63.17M -167.02M -149.89M -482.66M -134.90M
Cash (start) 72.21M 29.05M 21.86M 49.03M 37.12M
Cash (end) 29.05M 21.86M 49.03M 37.12M 101.55M
FCF 878.02M 287.32M 112.54M 211.92M 153.46M

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding Cash Flow

The cash flow statement tracks how Amrutanjan's cash moves through operations, investing, and financing activities. Free cash flow — operating cash minus capital expenditure — shows what is available to return to shareholders.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025

Related Stocks